In addition to malaria, tuberculosis, and human immunodeficiency virus infection, several
other infectious diseases are associated with substantial morbidity and mortality. In …

One of the most significant health problems in the American continent in terms of human
health, and socioeconomic impact is Chagas disease, caused by the protozoan parasite …

About 1.5 million new cases of cutaneous leishmaniasis and 500 000 new cases of visceral
leishmaniasis occur each year around the world. For over half a century, the clinical forms of …

A critical review of the development of specific chemotherapeutic approaches for the
management of American Trypanosomiasis or Chagas disease is presented, including …

Many develo** countries including Cameroon have mortality patterns that reflect high
levels of infectious diseases and the risk of death during pregnancy and childbirth, in …

Background Human African trypanosomiasis (HAT) is an important public health problem in
sub-Saharan Africa, affecting hundreds of thousands of individuals. An urgent need exists …

Parasitic diseases such as malaria, leishmaniasis, and trypanosomiasis represent a
significant global burden and pose a great challenge to drug discovery and delivery …

Companion vector-borne diseases (CVBDs) are an important threat for pet life, but may also
have an impact on human health, due to their often zoonotic character. The importance and …

Amphotericin B is a low-soluble polyene antibiotic which is able to self-aggregate. The
aggregation state can modify its activity and pharmacokinetical characteristics. In spite of its …

The causative species of cutaneous leishmaniasis determines the clinical features and
courses, and treatments. Intralesional or systemic antimonials are the gold standard for the …